WAT
VENTE TOTALE: 3 626 titres (~1 442 930,44 $ US)
- Insiders
- KUEBLER CHRISTOPHER A
- Total bought
- —
- Total sold
- $1,442,930
- Last activity
- 2026-08-06
- Last synced
-
2026-08-12 09:47:22
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-09
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 57.8% | 59.4% | 59.6% | 58.0% | 58.5% | |
| Ebit Margin | 25.5% | 28.5% | 28.2% | 29.8% | 30.6% | |
| Ebitda Margin | 32.0% | 35.0% | 33.9% | 34.2% | 35.3% | |
| Operating Profit Margin | 28.2% | 27.9% | 27.7% | 29.4% | 29.5% | |
| Pretax Profit Margin | 23.8% | 25.5% | 24.9% | 28.2% | 28.9% | |
| Continuous Operations Profit Margin | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% | |
| Net Profit Margin | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% | |
| Bottom Line Profit Margin | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% | |
| Current Ratio | 1.733 | 2.113 | 2.220 | 2.245 | 2.394 | |
| Quick Ratio | 1.271 | 1.509 | 1.566 | 1.665 | 1.870 | |
| Solvency Ratio | 0.337 | 0.304 | 0.232 | 0.302 | 0.302 | |
| Cash Ratio | 0.474 | 0.411 | 0.500 | 0.612 | 0.737 | |
| Price To Earnings Ratio | 35.169 | 34.510 | 30.288 | 29.032 | 33.120 | |
| Price To Earnings Growth Ratio | 75.614 | -31.260 | -3.843 | 5.938 | 0.976 | |
| Forward Price To Earnings Growth Ratio | 75.614 | -31.260 | -3.843 | 5.938 | 0.976 | |
| Price To Earnings Diluted Ratio | 35.300 | 34.639 | 30.372 | 29.205 | 33.357 | |
| Price To Earnings Diluted Growth Ratio | 75.613 | -28.883 | -4.003 | 5.825 | 0.992 | |
| Price To Book Ratio | 8.825 | 12.038 | 16.908 | 40.734 | 62.420 | |
| Price To Sales Ratio | 7.141 | 7.440 | 6.579 | 6.915 | 8.235 | |
| Price To Free Cash Flow Ratio | 41.873 | 35.523 | 43.986 | 47.990 | 39.624 | |
| Price To Operating Cash Flow Ratio | 34.638 | 28.882 | 32.265 | 33.596 | 30.702 | |
| Debt To Assets Ratio | 0.294 | 0.374 | 0.528 | 0.507 | 0.517 | |
| Debt To Equity Ratio | 0.582 | 0.931 | 2.123 | 3.297 | 4.357 | |
| Debt To Capital Ratio | 0.368 | 0.482 | 0.680 | 0.767 | 0.813 | |
| Long Term Debt To Capital Ratio | 0.270 | 0.471 | 0.667 | 0.751 | 0.805 | |
| Financial Leverage Ratio | 1.982 | 2.490 | 4.022 | 6.505 | 8.420 | |
| Working Capital Turnover Ratio | 3.542 | 3.211 | 3.046 | 3.085 | 3.608 | |
| Operating Cash Flow Ratio | 0.526 | 0.965 | 0.763 | 0.778 | 1.098 | |
| Operating Cash Flow Sales Ratio | 0.206 | 0.258 | 0.204 | 0.206 | 0.268 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.827 | 0.813 | 0.734 | 0.700 | 0.775 | |
| Debt Service Coverage Ratio | 1.699 | 10.252 | 6.093 | 8.978 | 19.348 | |
| Interest Coverage Ratio | 12.843 | 9.215 | 8.271 | 17.899 | 18.285 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.419 | 0.000 | 12.056 | 12.233 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.438 | 0.448 | 0.247 | 0.368 | 0.467 | |
| Capital Expenditure Coverage Ratio | 5.788 | 5.349 | 3.753 | 3.334 | 4.441 | |
| Dividend Paid And Capex Coverage Ratio | 5.788 | 5.349 | 3.753 | 3.334 | 4.441 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 23.230 | 22.568 | 21.475 | 21.368 | 24.464 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 57.8% | ▼-1.7% | ▼-0.9% |
| Ebit Margin | 25.4% | ▼-3.1% | ▼-3.1% |
| Ebitda Margin | 32.0% | ▼-3.1% | ▼-2.1% |
| Operating Profit Margin | 28.2% | ▲0.3% | ▼-0.3% |
| Pretax Profit Margin | 23.8% | ▼-1.7% | ▼-2.4% |
| Continuous Operations Profit Margin | 20.3% | ▼-1.3% | ▼-2.1% |
| Net Profit Margin | 20.3% | ▼-1.3% | ▼-2.1% |
| Bottom Line Profit Margin | 20.3% | ▼-1.3% | ▼-2.1% |
| Current Ratio | 1.733 | ▼-0.381 | ▼-0.408 |
| Quick Ratio | 1.271 | ▼-0.238 | ▼-0.305 |
| Solvency Ratio | 0.338 | ▲0.033 | ▲0.042 |
| Cash Ratio | 0.474 | ▲0.064 | ▼-0.072 |
| Price To Earnings Ratio | 35.169 | ▲0.660 | ▲2.746 |
| Price To Earnings Growth Ratio | 75.614 | ▲106.874 | ▲66.129 |
| Forward Price To Earnings Growth Ratio | 75.614 | ▲106.874 | ▲66.129 |
| Price To Earnings Diluted Ratio | 35.300 | ▲0.661 | ▲2.725 |
| Price To Earnings Diluted Growth Ratio | 75.613 | ▲104.496 | ▲65.704 |
| Price To Book Ratio | 8.825 | ▼-3.213 | ▼-19.360 |
| Price To Sales Ratio | 7.141 | ▼-0.299 | ▼-0.121 |
| Price To Free Cash Flow Ratio | 41.873 | ▲6.350 | ▲0.073 |
| Price To Operating Cash Flow Ratio | 34.638 | ▲5.756 | ▲2.622 |
| Debt To Assets Ratio | 0.294 | ▼-0.080 | ▼-0.150 |
| Debt To Equity Ratio | 0.582 | ▼-0.349 | ▼-1.676 |
| Debt To Capital Ratio | 0.368 | ▼-0.114 | ▼-0.254 |
| Long Term Debt To Capital Ratio | 0.270 | ▼-0.201 | ▼-0.323 |
| Financial Leverage Ratio | 1.982 | ▼-0.508 | ▼-2.702 |
| Working Capital Turnover Ratio | 3.542 | ▲0.331 | ▲0.243 |
| Operating Cash Flow Ratio | 0.526 | ▼-0.439 | ▼-0.300 |
| Operating Cash Flow Sales Ratio | 0.206 | ▼-0.051 | ▼-0.022 |
| Free Cash Flow Operating Cash Flow Ratio | 0.827 | ▲0.014 | ▲0.058 |
| Debt Service Coverage Ratio | 1.699 | ▼-8.553 | ▼-7.575 |
| Interest Coverage Ratio | 12.843 | ▲3.628 | ▼-0.459 |
| Short Term Operating Cash Flow Coverage Ratio | 1.419 | ▲1.419 | ▼-3.723 |
| Operating Cash Flow Coverage Ratio | 0.438 | ▼-0.010 | ▲0.044 |
| Capital Expenditure Coverage Ratio | 5.788 | ▲0.439 | ▲1.255 |
| Dividend Paid And Capex Coverage Ratio | 5.788 | ▲0.439 | ▲1.255 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 23.230 | ▲0.662 | ▲0.609 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $22.60B | $22.01B | $19.45B | $20.55B | $22.94B | |
| Enterprise value | $23.51B | $23.39B | $21.50B | $21.73B | $24.04B | |
| EV / Sales | 7.43x | 7.91x | 7.27x | 7.31x | 8.63x | |
| EV / Op. cash flow | 36.02x | 30.69x | 35.66x | 35.53x | 32.17x | |
| EV / Free cash flow | 43.55x | 37.75x | 48.62x | 50.75x | 41.52x | |
| EV / EBITDA | 23.23x | 22.57x | 21.48x | 21.37x | 24.46x | |
| Net debt / EBITDA | 0.89x | 1.33x | 2.04x | 1.16x | 1.12x | |
| Current ratio | 1.73x | 2.11x | 2.22x | 2.25x | 2.39x | |
| Income quality | 1.01x | 1.20x | 0.94x | 0.86x | 1.08x | |
| Graham number | $102 | $86 | $69 | $47 | $39 | |
| Graham net-net | -$17 | -$27 | -$39 | -$25 | -$25 | |
| Tax burden | 85.1% | 84.5% | 87.2% | 84.5% | 85.9% | |
| Interest burden | 93.7% | 89.4% | 88.2% | 94.5% | 94.7% | |
| Working capital | $908.1M | $879.4M | $963.3M | $978.2M | $948.4M | |
| Invested capital | $3.53B | $3.47B | $3.62B | $2.30B | $2.26B | |
| Return on assets | 12.7% | 14.0% | 13.9% | 21.6% | 22.4% | |
| Operating ROA | 18.6% | 18.0% | 20.7% | 27.4% | 27.7% | |
| Return on tangible assets | 20.2% | 23.7% | 23.9% | 27.0% | 28.7% | |
| Return on equity | 25.1% | 34.9% | 55.8% | 140.3% | 188.5% | |
| Return on invested capital | 17.6% | 18.4% | 18.2% | 28.7% | 28.9% | |
| Return on capital employed | 23.3% | 22.0% | 21.3% | 35.0% | 34.0% | |
| Earnings yield | 2.8% | 2.9% | 3.3% | 3.4% | 3.0% | |
| Free cash flow yield | 2.4% | 2.8% | 2.3% | 2.1% | 2.5% | |
| Capex / Op. cash flow | 17.3% | 18.7% | 26.6% | 30.0% | 22.5% | |
| Capex / Depreciation | 54.7% | 74.3% | 96.8% | 140.7% | 127.8% | |
| Capex / Sales | 3.6% | 4.8% | 5.4% | 6.2% | 6.0% | |
| SG&A / Sales | 23.4% | 23.3% | 24.9% | 22.1% | 22.5% | |
| R&D / Sales | 6.2% | 6.2% | 5.9% | 5.9% | 6.0% | |
| Stock comp / Sales | 1.7% | 1.5% | 1.2% | 1.4% | 1.1% | |
| Intangibles / Total assets | 37.4% | 40.9% | 41.8% | 20.0% | 22.0% | |
| Days sales outstanding | 96d | 90d | 87d | 89d | 80d | |
| Days payables outstanding | 28d | 30d | 26d | 27d | 31d | |
| Operating cycle | 252d | 236d | 244d | 222d | 193d | |
| Cash conversion cycle | 224d | 205d | 218d | 195d | 162d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+2.7%EV / Sales ▼-6.1%EV / EBITDA ▲+2.9%EV / Op. cash flow ▲+5.333Earnings yield ▼-0.001Graham number ▲+15.925
Profitability
Return on equity ▼-0.098Return on assets ▼-0.013Return on invested capital ▼-0.009Return on capital employed ▲+0.013Operating ROA ▲+0.005Income quality ▼-0.179Tax burden ▲+0.006
Efficiency
Days sales outstanding ▲+5.096Days payables outstanding ▼-2.051Operating cycle ▲+16.255Cash conversion cycle ▲+18.306Capex / Sales ▼-0.013R&D / Sales -0.000
Balance-sheet strength
Current ratio ▼-0.381Net debt / EBITDA ▼-0.437Working capital ▲+28793000.000Invested capital ▲+60844000.000Intangibles / Total assets ▼-0.035
Change over 5 years
Valuation
Market cap ▼-1.5%EV / Sales ▼-14.0%EV / EBITDA ▼-5.0%EV / Op. cash flow ▲+3.848Earnings yield ▼-0.002Graham number ▲+63.387
Profitability
Return on equity ▼-1.634Return on assets ▼-0.097Return on invested capital ▼-0.113Return on capital employed ▼-0.108Operating ROA ▼-0.091Income quality ▼-0.063Tax burden ▼-0.008
Efficiency
Days sales outstanding ▲+15.309Days payables outstanding ▼-2.210Operating cycle ▲+59.228Cash conversion cycle ▲+61.438Capex / Sales ▼-0.025R&D / Sales ▲+0.001
Balance-sheet strength
Current ratio ▼-0.661Net debt / EBITDA ▼-0.227Working capital ▼-40288000.000Invested capital ▲+1267869000.000Intangibles / Total assets ▲+0.154
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-04-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-03-10 | Thomas H. Kean | Sale | $1,001 - $15,000 |
| 2026-02-13 | Thomas H. Kean | Sale (Partial) | $1,001 - $15,000 |
| 2026-02-10 | Debbie Dingell | receive | $1,001 - $15,000 |
| 2026-02-09 | Kevin Hern | Exchange | $1,001 - $15,000 |
| 2025-12-08 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2025-09-30 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-26 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-08-13 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-08-12 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-07-22 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-07-16 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Rob Bresnahan | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2024-11-19 | Julia Letlow | Sale (Full) | $1,001 - $15,000 |
| 2024-11-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-10-23 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel | Sale | $1,001 - $15,000 |
| 2023-06-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-01-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-08-04 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
Recent news
- 2026-08-10 Dudley & Shanley Inc. Has $8.85 Million Stake in Waters Corporation $WAT Dudley and Shanley Inc. raised its holdings in Waters Corporation (NYSE: WAT) by 101.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,590 shares of the medical instruments supplier''s stock after purchasing an additional 11,870 shares during the period. Waters makes
- 2026-08-10 Waters (NYSE:WAT) Director Sells $1,442,930.44 in Stock Waters Corporation (NYSE: WAT - Get Free Report) Director Christopher Kuebler sold 3,626 shares of Waters stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares in the company, valued
- 2026-08-09 Waters Q2 Earnings Call Highlights Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic Solutions businesses. The company raised its full-year outlook for organic revenue, acquired-business revenue and adjusted earnings per share after results exceeded its prior guidance.
- 2026-08-06 Waters Corporation $WAT Shares Acquired by Empowered Funds LLC Empowered Funds LLC lifted its stake in Waters Corporation (NYSE: WAT) by 431.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,954 shares of the medical instruments supplier''s stock after purchasing an additional 6,456 shares during the period. Empowered
- 2026-08-05 Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised WAT tops Q2 estimates, raises its 2026 outlook and posts broad-based growth across organic and acquired businesses.
- 2026-08-05 Cetera Investment Advisers Grows Stock Holdings in Waters Corporation $WAT Cetera Investment Advisers increased its stake in Waters Corporation (NYSE: WAT) by 121.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,097 shares of the medical instruments supplier''s stock after buying an additional 7,172 shares during the period. Cetera Investment Advisers'' holdings
- 2026-08-04 Waters Corporation (WAT) Q2 2026 Earnings Call Transcript Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
- 2026-08-04 Waters (WAT) Q2 Earnings and Revenues Beat Estimates Waters (WAT) came out with quarterly earnings of $3.05 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.95 per share a year ago.
- 2026-08-04 Is Waters Corp (WAT) Holding Value Amidst Q2 Losses? Earnings Beat Estimates with Revenue of $1.645 Billion -- GF Score: 94/100 Waters Corp (WAT) released its 8-K filing on August 4, 2026, presenting a robust performance for the second quarter of 2026 that surpassed analyst expectations
- 2026-08-04 Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results Second Quarter 2026 Highlights Total reported revenue of $1.645 billion surpassed the high end of the guidance range, driven by broad-based outperformance across both organic revenue and the acquired businesses. Organic revenue of $828 million grew 7% as reported and 9% in constant currency; the Analytical Sciences Division (ASD) delivered 8% instrument growth and double-digit chemistry consumables growth, led by low-double-digit growth in both Pharma and A&G end markets, in constant currency, as the market recovery has entered a broader phase, expanding across additional customer segments.